A cost-effectiveness analysis of Onabotulinumtoxin A as first-line treatment for overactive bladder
Crossref DOI link: https://doi.org/10.1007/s00192-018-3653-z
Published Online: 2018-04-18
Published Print: 2018-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shepherd, Jonathan P.
Carter-Brooks, Charelle M.
Chermanksy, Christopher
Text and Data Mining valid from 2018-04-18
Article History
Received: 25 December 2017
Accepted: 3 April 2018
First Online: 18 April 2018
Compliance with ethical standards
:
: None.